Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Intimation of Schedule of Analysts / Institutional Investors meeting under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting with Investors and Analysts on Tuesday, February 25, 2020. This is to further inform that the Investor Presentation 'February 2020' to be shared with investors in the above interaction is available on BSE Limited's website - www.bseindia.com. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly note that changes may happen due to exigencies on the part of Host / Company.
24-02-2020
Bigul

Fermenta Biotech Ltd - 506414 - Intimation Of Schedule Of Analysts / Institutional Investors Meeting Under The SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015

 Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting with Investors and Analysts on Friday, February 21, 2020. This is to further inform that the Investor Presentation 'February 2020' to be shared with investors in the above interaction is available on BSE Limited's website - www.bseindia.com. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly note that changes may happen due to exigencies on the part of Host / Company.
20-02-2020
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby enclose a copy of Investor Relations Presentation for February 2020 for your information. The said Investor Presentation is also available on Company's website at www.dil.net Kindly take the same on records.
19-02-2020
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Allotment

 This is to inform you that pursuant to members' approval by way of postal ballot including e-voting dated January 28, 2020, the Business Restructuring Committee of the Board of Directors of the Company ('Committee') at its meeting held on February 15, 2020 has, inter alia, approved the allotment of 1,96,20,658 bonus equity shares of Rs. 5/- each as fully paid-up bonus equity shares, in the proportion of 2:1 i.e. 2 (Two) new fully paid-up equity shares of Rs. 5/- (Rupees Five only) each for every 1 (One) existing fully paid-up equity share of Rs. 5/- (Rupees Five only) each to members whose names appeared in the Register of Members / List of Beneficial Owners as on the Record Date i.e. February 14, 2020 fixed for this purpose.
15-02-2020
Bigul

Fermenta Biotech Ltd - 506414 - Publication Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31,2019

 Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our intimation given vide our letter bearing Ref: F.No.:49/2019-20 dated February 12, 2020 regarding declaration of Unaudited Financial Results for the quarter and nine months ended December 31, 2019, we are enclosing herewith photocopies of newspaper publications for your reference and record.
14-02-2020
Bigul

Fermenta Biotech Ltd - 506414 - Disclosure Of Events Or Information Under Reg. 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('ESOP 2019')

 Pursuant to Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 and subject to the provisions of the SEBI (Share Based Employee Benefits) Regulations, 2014 (hereinafter referred to as 'SEBI Regulations') and in accordance with ESOP 2019, the Nomination and Remuneration Committee ('Committee') at its meeting held on February 12, 2020 has approved the grant of 23,427 options (Twenty Three Thousand Four Hundred Twenty Seven only) to the eligible employees, exercisable into not more than 23,427 equity shares of face value of Rs. 5/- each of the Company, fully paid-up.
12-02-2020
Bigul

Fermenta Biotech Ltd - 506414 - Intimation Of Earnings Release Dated February 12, 2020

 Further to our intimation regarding approval of Unaudited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and nine months ended December 31, 2019, we hereby enclose a copy of Earnings Release of the Company for the quarter and nine months ended December 31, 2019. The said Earnings Release is also available on Company's website www.dil.net Kindly take the same on records.
12-02-2020
Bigul

Fermenta Biotech Ltd - 506414 - Quarterly And Nine Months Ended December 31, 2019

 We write to inform you that the Board of Directors of the Company at its meeting held on February 12, 2020 has approved the unaudited financial results for the quarter and nine months ended December 31, 2019 (Standalone and Consolidated) as enclosed. We are enclosing herewith Limited Review Report dated February 12, 2020 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Company's Statutory Auditors, Deloitte Haskins & Sells LLP. The Board meeting commenced at 10:45 a.m. and concluded at 12:55 p.m.
12-02-2020
Bigul

Fermenta Biotech Ltd - 506414 - Outcome Of Board Meeting And Financial Results - Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')

 We write to inform you that the Board of Directors of the Company at its meeting held on February 12, 2020 has approved the unaudited financial results for the quarter and nine months ended December 31, 2019 (Standalone and Consolidated) as enclosed. We are enclosing herewith Limited Review Report dated February 12, 2020 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Company's Statutory Auditors, Deloitte Haskins & Sells LLP. The Board meeting commenced at 10:45 a.m. and concluded at 12:55 p.m.
12-02-2020
Bigul

Fermenta Biotech Ltd - 506414 - Fermenta Biotech Limited (Formerly Known As DIL Limited) - Publication Of Notice Of Revised Record Date - February 14, 2020

 Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our intimation given vide our letter dated February 05, 2020 (sent through BSE website) regarding 'Revised Record Date' for proposed issue of 1,96,20,658 Bonus Equity Shares of Rs. 5 each of the Company, we are enclosing herewith photocopy of the newspaper publication published in Business Standard, Mumbai (English version) on page no. 5 and Sakal, Mumbai (Marathi version) on page no. 6 dated February 07, 2020 your reference and record.
07-02-2020
Next Page
Close

Let's Open Free Demat Account